In this issue:
Vonoprazan- vs. PPI-based third-line triple therapy for H. pylori
Predicting anti-TNF treatment failure in active luminal Crohn’s
Economics of chromocolonoscopy for detecting proximal serrated neoplasia
NAFLD prevalence, incidence and outcomes in Asia
Cost effectiveness of H. pylori population screening
Lactoferrin and lysozyme supplementation reduces environmental enteric dysfunction
Elevated liver enzymes and CV mortality
The significance of the small adenoma
Promotility agents: gastric emptying and upper GI symptoms
FMT is superior to fidaxomicin for recurrent C. difficile
Please login below to download this issue (PDF)